← Back to Search

Antimicrobial Agent

Next Science for Surgical Site Infection

N/A

Waitlist Available

Led By Robert Harris, MD

Research Sponsored by Next Science TM

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days

Awards & highlights

Study Summary

This trial is testing a new treatment for tibial fractures to see if it is safe and effective.

Eligible Conditions

Surgical Site Infection

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Surgical Site Infection

Secondary outcome measures

Deep Bioburden

Superficial Bioburden

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Standard of Care plus Next ScienceExperimental Treatment1 Intervention

In addition to the SoC, the blinded product will be applied in place of saline irrigation as the wound is closed (after bone fracture preparation/fixation), depending on the randomization.

Group II: Standard of CareActive Control1 Intervention

Each of the following procedures will be conducted according to general or local site Standard of Care (SoC): Medication administration at surgery Surgical irrigation and wound debridement Surgical fracture preparation/fixation Surgical closure

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Hughston ClinicOTHER

1 Previous Clinical Trials

130 Total Patients Enrolled

IACT HealthUNKNOWN

Next Science TMLead Sponsor

15 Previous Clinical Trials

9,507 Total Patients Enrolled

Media Library

Next Science Solution (Antimicrobial Agent) Clinical Trial Eligibility Overview. Trial Name: NCT04906642 — N/A

Surgical Site Infection Research Study Groups: Standard of Care, Standard of Care plus Next Science

Surgical Site Infection Clinical Trial 2023: Next Science Solution Highlights & Side Effects. Trial Name: NCT04906642 — N/A

Next Science Solution (Antimicrobial Agent) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04906642 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any unfilled slots in this experiment that require participation?

"Clinicaltrials.gov displays that this medical trial, which was originally posted on May 4th 2021, is still enrolling patients. The last update to the study took place on September 29th 2022."

Answered by AI

How many participants has this clinical experiment recruited thus far?

"Affirmative. Clinicaltrials.gov's records indicate that this examination is actively looking for volunteers, with the original posting having been made on May 4th 2021 and last updated September 29th 2022. The research requires 30 patients to be signed up from two sites."

Answered by AI

Could I be eligible to take part in this research project?

"This clinical trial has a limited sample size of 30 individuals and is open to those between 18-65 years old with surgical wounds."

Answered by AI

Is this investigation allowing participants of twenty years and older to partake?

"The study's guidelines state that only persons aged 18 to 65 may apply. For those younger than 18, there are 214 clinics available; for seniors over the age of 65, 706 options exist."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures

2021. "Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04906642.